GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ani Pharmaceuticals Inc. (ANIP) [hlAlert]

Rating:
Positive BPAX
down 67.26 %

BIOSANTE PHARMA INC (BPAX) rated Positive by Susquehanna Financial

Posted on: Thursday,  Jun 5, 2008  8:25 AM ET by Susquehanna Financial

Susquehanna Financial rated Positive Ani Pharmaceuticals Inc. (NASDAQ: ANIP) on 06/05/2008, when the stock price was $146.52. Since
then, Ani Pharmaceuticals Inc. has lost 67.26% as of 01/05/2016's recent price of $47.97.
If you would have followed this Susquehanna Financial's recommendation on ANIP, you would have lost 67.26% of your investment in 2770 days.

Biosante Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. The Company primary products include gel formulations of testosterone and estradiol. It is also engaged in the development of its calcium phosphate nanotechnology (CaP), primarily for aesthetic medicine, vaccines and drug delivery. The Company?s principal products include LibiGel, Bio-T-Gel and Pill-Plus. The Company?s CaP products in development include BioLook, BioVant, BioOral and BioAir. In October 2009, BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc. announced the completion of the merger of Cell Genesys, Inc. with and into BioSante Pharmaceuticals, Inc., with BioSante Pharmaceuticals, Inc. as the surviving company. Pursuant to the merger, BioSante Pharmaceuticals, Inc. has acquired all of the outstanding shares of Cell Genesys, Inc.

Since its inception in 1987, the Susquehanna International Group of Companies (SIG)* has grown from a trading firm on the Philadelphia Stock Exchange to one of the largest privately held financial institutions in the world. With more than 1,500 employees worldwide, SIG sits at the helm of the latest trends and developments in trading and market making, institutional sales, research, private equity, venture capital, and investment banking. SIG has offices across North America, Europe, Asia, and Australia. SIG distinguishes itself through its global market presence, capital commitment, and its grasp of trading dynamics. It excels at decision theory and implementing sophisticated pricing probability models.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/5/2008 8:25 AM Buy
None
146.52
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy